U-47700

1. 2026-10-19issueIssued info_card
2. 2026-09-07srcIn silico characterization of ligand-receptor interactions for U-47700, N,N-didesmethyl-U-47700, U-50488 at mu- and kappa-opioid receptors
3. 2026-09-07srcMetabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users
4. 2026-09-07srcAnalysis of fentanyl analogs and novel synthetic opioids in blood, serum/plasma, and urine in forensic casework
5. 2026-09-07srcDesigner drugs: mechanism of action and adverse effects
6. 2026-09-07srcCharacterization of recent non-fentanyl synthetic opioids via three different in vitro mu-opioid receptor activation assays
7. 2026-09-07srcCase report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700
8. 2026-09-07srcAnother fatal case related to the recreational abuse of U-47700
9. 2026-09-07srcClinical Pharmacokinetics and Pharmacodynamics of Naloxone
10. 2026-09-07srcPostmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug
11. 2026-09-07srcToxic lifespan of the synthetic opioid U-47,700 in Finland verified by re-analysis of UPLC-TOF-MS data
12. 2026-09-07srcMultiplex detection of 14 fentanyl analogues and U-47700 in biological samples: Application to a panel of French hospitalized patients
13. 2026-09-07srcPharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace
14. 2026-09-07srcPharmacodynamics and pharmacokinetics of the novel synthetic opioid, U-47700, in male rats
15. 2026-09-07srcRat-to-human PBPK model of U-47700: Unveiling pharmacokinetic risks of a synthetic opioid through interspecies extrapolation
16. 2026-09-07srcDARK Classics in Chemical Neuroscience: U-47700
17. 2026-09-07srcNear death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class
18. 2026-09-07srcA Fatality Related to the Synthetic Opioid U-47700: Postmortem Concentration Distribution
19. 2026-09-07srcMultiple Drug-Toxicity Involving Novel Psychoactive Substances, 3-Fluorophenmetrazine and U-47700
20. 2026-09-07srcChallenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids
21. 2026-09-07srcTo Test or Not To Test?: The Value of Toxicology in a Delayed Overdose Death
22. 2026-09-07srcDeaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016.
23. 2026-09-07srcDevelopment of a vaccine against the synthetic opioid U-47700
24. 2026-09-07srcAn Expanding World of Novel Psychoactive Substances: Opioids
25. 2026-09-07srcAnalysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework
26. 2026-09-07srcSchedules of Controlled Substances: Temporary Placement of U-47700 Into Schedule I. Final order
27. 2026-09-07srcCanada Gazette: Regulations Amending Schedule I to the Controlled Drugs and Substances Act (U-47700)
28. 2026-09-07srcCircular 008/2017: A change to the Misuse of Drugs Act 1971 to control U-47700
29. 2026-09-07srcUNODC Substance Details: U-47700 (CID 237db0fd)
30. 2026-09-07srcDEA Schedules Deadly Synthetic Drug U-47700 - Press Release
31. 2026-09-04issueIssued emergency
32. 2026-09-04issueIssued info_card
33. 2026-09-04issueIssued notice
34. 2026-06-04proposal26 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
35. 2026-06-04publicationPublication — backfill
36. 2026-05-08revisionRevision 1
37. 2026-05-08absenceSearched ClinicalTrials.gov for "U-47700" — no results
38. 2026-05-08absenceSearched ClinicalTrials.gov for "U-47700" — no results
39. 2026-05-08genGeneration — pipeline-v5 · with 3 morepipeline-v5
40. 2026-05-08rungeneration run

The same entries, as forms: six forms.